Heparanase promotes angiogenesis through Cox-2 and HIF1α

Medical Hypotheses

Volumn 68, Issue 1, 2007, Pages 162-165

  Naomoto, Yoshio ^a   Gunduz, Mehmet ^a   Takaoka, Munenori ^a   Okawa, Takaomi ^a   Gunduz, Esra ^a   Nobuhisa, Tetsuji ^a   Kobayashi, Masahiko ^a   Shirakawa, Yasuhiro ^a   Yamatsuji, Tomoki ^a   Sonoda, Ryutaro ^a   Matsuoka, Junji ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; CYCLOOXYGENASE 2; HEPARANASE; HETERODIMER; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ARTICLE; BINDING SITE; CANCER INVASION; COLON CARCINOMA; CORRELATIONAL STUDY; ESOPHAGUS CARCINOMA; HUMAN; HYPOTHESIS; HYPOXIC CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN BINDING; STOMACH CANCER; TUMOR GROWTH; UPREGULATION;

EID: 33750620149     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.03.055     Document Type: Article

References (21)

1. Eccles S.A. Heparanase: breaking down barriers in tumors. Nat Med 5 7 (1999) 735-736
2. Vlodavsky I., Friedmann Y., Elkin M., Aingorn H., Atzmon R., Ishai-Michaeli R., et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5 7 (1999) 793-802
3. Parish C.R., Freeman C., and Hulett M.D. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471 3 (2001) M99-M108
4. Nadav L., Eldor A., Yacoby-Zeevi O., Zamir E., Pecker I., Ilan N., et al. Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J Cell Sci 115 Pt 10 (2002) 2179-2187
5. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J., et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68 (1999) 729-777
6. Elkin M., Ilan N., Ishai-Michaeli R., Friedmann Y., Papo O., Pecker I., et al. Heparanase as mediator of angiogenesis: mode of action. FASEB J 15 9 (2001) 1661-1663
7. El-Assal O.N., Yamanoi A., Ono T., Kohno H., and Nagasue N. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma. Clin Cancer Res 7 5 (2001) 1299-1305
8. Koliopanos A., Friess H., Kleeff J., Shi X., Liao Q., Pecker I., et al. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 61 12 (2001) 4655-4659
9. Gohji K., Okamoto M., Kitazawa S., Toyoshima M., Dong J., Katsuoka Y., et al. Heparanase protein and gene expression in bladder cancer. J Urol 166 4 (2001) 1286-1290
10. Wang Z., Xu H., Jiang L., Zhou X., Lu C., and Zhang X. Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinoma. Mod Pathol 18 2 (2005) 205-211
11. Naomoto Y., Takaoka M., Okawa T., Nobuhisa T., Gunduz M., and Tanaka N. The role of heparanase in gastrointestinal cancer. Oncol Rep 14 1 (2005) 3-8
12. Hull M.A. Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?. Eur J Cancer 41 13 (2005) 1854-1863
13. Leahy K.M., Koki A.T., and Masferrer J.L. Role of cyclooxygenases in angiogenesis. Curr Med Chem 7 11 (2000) 1163-1170
14. Schubert S.Y., Ilan N., Shushy M., Ben-Izhak O., Vlodavsky I., and Goldshmidt O. Human heparanase nuclear localization and enzymatic activity. Lab Invest 84 5 (2004) 535-544
15. Ohkawa T., Naomoto Y., Takaoka M., Nobuhisa T., Noma K., Motoki T., et al. Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation. Lab Invest 84 10 (2004) 1289-1304
16. Okawa T., Naomoto Y., Nobuhisa T., Takaoka M., Motoki T., Shirakawa Y., et al. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2. Clin Cancer Res 11 22 (2005) 7995-8005
17. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93 4 (2001) 266-276
18. Maxwell P.H. The HIF pathway in cancer. Semin Cell Dev Biol 16 4-5 (2005) 523-530
19. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9 6 (2003) 677-684
20. Brennan P.A., Mackenzie N., and Quintero M. Hypoxia-inducible factor 1α in oral cancer. J Oral Pathol Med 34 7 (2005) 385-389
21. He X., Brenchley P.E., Jayson G.C., Hampson L., Davies J., and Hampson I.N. Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies. Cancer Res 64 11 (2004) 3928-3933